Mechanical characterization of bio composite films as a novel drug carrier platform for sustained release of 5-fluorouracil for colon cancer: Methodological investigation.

In this study, we employed Pectin (PC) as a matrix that is hybridized with three different nucleobase (NB) units (cytosine, thymine, uracil) to generate pectin-nucleobase(PC-NB) biocomposite films stabilized through bio-multiple hydrogen bonds (BMHBs) as drug carrier for anticancer 5-Fluorouracil (5-FU). Prepared biocomposite films were characterized by Fourier Transform Infra-red Spectroscopy (FTIR), X-ray Diffraction (XRD), Thermogravimmetry Analysis (TGA) and Scanning Electron Microscope (SEM). Mechanical and sorption properties were also evaluated. In vitro drug release performed in both acidic pH 1.2 (stomach pH) and alkaline pH 7.4 (intestinal pH) showed that incorporation of nucleobases into pectin significantly restricted release rate of 5-FU particularly under acidic condition (pH 1.2). Hemolysis assays demonstrated that PC-NB-5-FU biocomposite film drug carriers were hemocompatible. Confocal microscope analysis indicates facilitated cellular uptake of PC-NB-5-FU film in HT-29 colon cancer cell line, which in turn result in a higher potential of apoptosis. Confocal imaging of fluorescent live/dead cell indicators and MTT assay outcomes, both demonstrated significant decreases in cellular viability of PC-NB-5-FU biocomposite films. Collectively, our findings indicate that this PC-NB-5-FU biocomposite films can be conferred as a proficient formulation for targeted delivery of colon cancer drugs.

Fabrication and characterization of poly(vinyl alcohol)-TiO2 nanocomposite films for orthopedic applications.

Poly(vinyl alcohol) (PVA) is reinforced with TiO2 nanoparticles in order to enhance thermo-mechanical stabilities, surface characteristics and osteoblastic cell adhesion. PVA-TiO2 nanocomposite films with desirable mechanical, thermal and biocompatible properties are fabricated through solution casting method followed by de-hydrothermal cross-linking treatment. The composition of TiO2 nanoparticles was standardized to achieve mechanically stable nanocomposite films, based on tensile strength measurements composition of TiO2 is determined as optimal at 3wt%. PVA-TiO2 nanocomposite films were characterized by Scanning electron microscopy, Energy dispersive spectroscopy, Atomic force microscopy, Ultra violet and Fourier transform infrared spectroscopic techniques. Elemental mapping studies substantiate incorporation of TiO2 nanoparticles within the PVA matrix. Dimensional stability evaluated by soaking films in SBF for 24h insinuates the role of TiO2 in the direction of controlling degree of swelling. In-vitro bioactivity test and cell adhesion results also predict that presence of TiO2 is advantageous to enhance apatite growth and promote cell-substrate interaction. SEM studies illustrate improved surface morphology of PVA-TiO2 nanocomposite film with homogenously distributed TiO2 nanoparticles, which help to enhance thermo-mechanical behavior. TiO2 nanoparticles construct cell-adhesive hydrophilic nano-domains that act as potential cell adhesion sites and promotes osteointegration. Bio compatibility studies proved that thermally cross-linked PVA is non-toxic in relation to PVA cross-linked with glutaraldehyde. Cytotoxicity and cell adhesion of nanocomposite films evaluated through cell viability (MMT) assay and crystal violet staining revealed that PVA-3wt% TiO2nanocomposite could act as an excellent composite and hence suitable to be used in bone implant applications.

Fabrication of TiO2-SiO2 bioceramic coatings on Ti alloy and its synergetic effect on biocompatibility and corrosion resistance.

Most of the research work focussed on fabricating an implant material with an ideal combination of potential bioactivity on the surface and striking mechanical property of bulk in one elementary operation. Interwoven with above concept, SiO2 incorporated nanostructured titania coatings were fabricated on Ti alloy by anodization using sodium silico fluoride electrolyte (SSF). The coatings were characterized by SEM, EDS, AFM, XRD and AT-FTIR techniques. The bioactivity and biocompatibility of the anodic coatings were also investigated. The AT-FTIR, EDS and XRD studies confirm the incorporation of SiO2 into TiO2 coating was confirmed by EDS, XRD and AT-FTIR techniques. The coating formed at the optimum conditions displays a dome like structure with nano flake morphology with maximum mechanical and anticorrosion properties. AFM analysis inferred that the surface roughness of the ceramic coating is higher compared to the pure titania. The SBF test and cell adhesion results predicted that SiO2 incorporated TiO2 coating is superior in their bioactivity compared to TiO2 coating.